Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

NNZ 2591

NNZ 2591 is an orally active, blood-brain barrier permeable cyclic glycine-proline analogue. It has demonstrated neuroprotective effects in rodent models of ischemic brain injury and Parkinson's disease, supporting its research potential for conditions like Angelman syndrome.

Product Specifications

Molecular Weight

194.23

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Compound Fr13169
orb3170036-01 1 mg

Compound Fr13169

Sign In for Pricing
View Details
Compound Fr13169
orb3170036-02 5 mg

Compound Fr13169

Sign In for Pricing
View Details
Rbm14 3'UTR GFP Stable Cell Line
TU167607 1.0 mL

Rbm14 3'UTR GFP Stable Cell Line

Sign In for Pricing
View Details
TGFB1 (Transforming Growth Factor, beta 1, CED, DPD1, TGFB, TGFbeta) (FITC)
MBS6178562-01 0.1 mL

TGFB1 (Transforming Growth Factor, beta 1, CED, DPD1, TGFB, TGFbeta) (FITC)

Sign In for Pricing
View Details
TGFB1 (Transforming Growth Factor, beta 1, CED, DPD1, TGFB, TGFbeta) (FITC)
MBS6178562-02 5x 0.1 mL

TGFB1 (Transforming Growth Factor, beta 1, CED, DPD1, TGFB, TGFbeta) (FITC)

Sign In for Pricing
View Details
PDIK1L discontinued
392884 200 µL

PDIK1L discontinued

Sign In for Pricing
View Details